Glass House uplists medical cannabis to the New York Stock Exchange on Tuesday after restructuring its U.S. operations to focus on medical-only production and registration with federal authorities. The California cultivator becomes the second U.S. plant-touching cannabis company to list on the NYSE, following Florida multistate operator Trulieve.
Company structure and listing steps Glass House separated its medical and adult-use businesses before applying to the NYSE. It reclassified its Southern California cultivation operations as medical-only and moved its California adult-use retail operation into a related but legally distinct entity, Glass House Retail. According to documents filed with the Canadian Securities Exchange, a Glass House subsidiary retains 90% ownership of Glass House Retail while outside investor NSJB Investments acquired 10% for approximately $2.5 million.
Glass House President Graham Farrar said the company pursued registration with the U.S. Drug Enforcement Administration after the Justice Department issued a final order in April reclassifying state-licensed medical cannabis as a Schedule III drug. That federal registration contributed to meeting NYSE listing standards, Farrar told MJBizDaily.
Market reaction and valuation Shares of Glass House, which traded on over-the-counter (OTC) markets ahead of the uplisting, rose from $11.01 at the close of trading on Wednesday to $12.30 near the close on Friday. Based on recent trading, the company’s market value approached $1.0 billion.
How Glass House differs from other applicants Other large U.S. cannabis operators, including Curaleaf Holdings and Verano Holding Corp., have announced reverse stock splits to meet NYSE minimum share-price rules but retain adult-use operations. Glass House’s approach was to isolate its medical cultivation and seek DEA registration tied explicitly to medical distribution, which the company says aligns it with NYSE requirements for plant-touching businesses.
Regulatory and operational actions Glass House said it is working with California regulators to establish legal channels to export cannabis products to other DEA-licensed entities. The company told regulators and investors it completed the corporate segregation necessary for a U.S. securities exchange listing and spent roughly a year in contact with the NYSE before applying.
ICE raids, DCC fine, and appeal Separately, Glass House has been dealing with legal and compliance matters stemming from Immigration and Customs Enforcement (ICE) raids at its Ventura and Santa Barbara county properties last July. More than 300 people were detained in those raids, and authorities reported one worker died after falling from a roof while hiding.
The California Department of Cannabis Control (DCC) issued a $21,000 fine to Glass House for failing to maintain adequate procedures and documentation to verify and record worker ages at its operations. Glass House has formally appealed that fine. The DCC also noted that a regulatory visit in May — preceding the ICE action — found no minors on site.
State and federal age rules California allows agricultural workers as young as 14 to work in general agriculture, but cannabis-specific rules require workers to be at least 21. The DCC’s citation focused on documentation and verification procedures rather than a confirmed presence of minors during its May inspection.
What this means for the market Glass House’s uplisting to the NYSE signals that at least one large U.S. cultivator has met listing conditions by isolating medical operations and pursuing DEA registration tied to the Justice Department’s reclassification. Investors reacted by bidding up shares on OTC markets in the days before the listing. Whether other plant-touching companies will follow the same path depends on their willingness to separate adult-use activities or to align with federal registration and NYSE rules.
Next steps Glass House begins trading on the NYSE Tuesday. The company continues to pursue regulatory approvals for federal registration and interstate transfers to DEA-licensed operators where permitted, and it awaits the outcome of its appeal of the DCC fine.
Key figures at a glance – NYSE listing date: Tuesday (company announcement) – Recent OTC share move: $11.01 (end of trading Wednesday) to $12.30 (near close Friday) – Implied valuation: about $1.0 billion based on recent trading – Glass House Retail outside stake: 10% sold to NSJB Investments for about $2.5 million – DCC fine: $21,000 (appealed) – Number detained in ICE raids: more than 300 – Age rules: agricultural workers can be 14+ in general agriculture; cannabis workers must be 21+
Glass House’s NYSE listing tests whether exchange rules and federal registration can produce a clear path for at least some U.S. plant-touching cannabis companies to access major U.S. capital markets without retaining adult-use operations on the same corporate balance sheet.
